These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 32271701

  • 1. Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020.
    Veliziotis I, Roman A, Martiny D, Schuldt G, Claus M, Dauby N, Van den Wijngaert S, Martin C, Nasreddine R, Perandones C, Mahieu R, Swaan C, Van Praet S, Konopnicki D, Morales MA, Malvy D, Stevens E, Dechamps P, Vlieghe E, Vandenberg O, Günther S, Gérard M.
    Emerg Infect Dis; 2020 Jul; 26(7):1562-1566. PubMed ID: 32271701
    [Abstract] [Full Text] [Related]

  • 2. Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever.
    Gowen BB, Juelich TL, Sefing EJ, Brasel T, Smith JK, Zhang L, Tigabu B, Hill TE, Yun T, Pietzsch C, Furuta Y, Freiberg AN.
    PLoS Negl Trop Dis; 2013 Jul; 7(12):e2614. PubMed ID: 24386500
    [Abstract] [Full Text] [Related]

  • 3. Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.
    Westover JB, Sefing EJ, Bailey KW, Van Wettere AJ, Jung KH, Dagley A, Wandersee L, Downs B, Smee DF, Furuta Y, Bray M, Gowen BB.
    Antiviral Res; 2016 Feb; 126():62-8. PubMed ID: 26711718
    [Abstract] [Full Text] [Related]

  • 4. Potential and action mechanism of favipiravir as an antiviral against Junin virus.
    Zadeh VR, Afowowe TO, Abe H, Urata S, Yasuda J.
    PLoS Pathog; 2022 Jul; 18(7):e1010689. PubMed ID: 35816544
    [Abstract] [Full Text] [Related]

  • 5. Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy.
    Gowen BB, Westover JB, Sefing EJ, Van Wettere AJ, Bailey KW, Wandersee L, Komeno T, Furuta Y.
    Antiviral Res; 2017 Sep; 145():131-135. PubMed ID: 28780425
    [Abstract] [Full Text] [Related]

  • 6. Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever.
    Mendenhall M, Russell A, Smee DF, Hall JO, Skirpstunas R, Furuta Y, Gowen BB.
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1342. PubMed ID: 22022624
    [Abstract] [Full Text] [Related]

  • 7. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
    Hawman DW, Haddock E, Meade-White K, Williamson B, Hanley PW, Rosenke K, Komeno T, Furuta Y, Gowen BB, Feldmann H.
    Antiviral Res; 2018 Sep; 157():18-26. PubMed ID: 29936152
    [Abstract] [Full Text] [Related]

  • 8. Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.
    Madelain V, Duthey A, Mentré F, Jacquot F, Solas C, Lacarelle B, Vallvé A, Barron S, Barrot L, Mundweiler S, Thomas D, Carbonnelle C, Raoul H, de Lamballerie X, Guedj J.
    Antiviral Res; 2020 May; 177():104758. PubMed ID: 32135218
    [Abstract] [Full Text] [Related]

  • 9. Guinea Pig Transferrin Receptor 1 Mediates Cellular Entry of Junín Virus and Other Pathogenic New World Arenaviruses.
    Hickerson BT, Westover JB, Wang Z, Lee YM, Gowen BB.
    J Virol; 2020 Jan 31; 94(4):. PubMed ID: 31748396
    [Abstract] [Full Text] [Related]

  • 10. Effect of ribavirin on junin virus infection in guinea pigs.
    Salazar M, Yun NE, Poussard AL, Smith JN, Smith JK, Kolokoltsova OA, Patterson MJ, Linde J, Paessler S.
    Zoonoses Public Health; 2012 Jun 31; 59(4):278-85. PubMed ID: 22212688
    [Abstract] [Full Text] [Related]

  • 11. Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever.
    McKee KT, Huggins JW, Trahan CJ, Mahlandt BG.
    Antimicrob Agents Chemother; 1988 Sep 31; 32(9):1304-9. PubMed ID: 2848441
    [Abstract] [Full Text] [Related]

  • 12. The glycoprotein precursor gene of Junin virus determines the virulence of the Romero strain and the attenuation of the Candid #1 strain in a representative animal model of Argentine hemorrhagic fever.
    Seregin AV, Yun NE, Miller M, Aronson J, Smith JK, Walker AG, Smith JN, Huang C, Manning JT, de la Torre JC, Paessler S.
    J Virol; 2015 Jun 31; 89(11):5949-56. PubMed ID: 25810546
    [Abstract] [Full Text] [Related]

  • 13. Junín Virus Promotes Autophagy To Facilitate the Virus Life Cycle.
    Roldán JS, Candurra NA, Colombo MI, Delgui LR.
    J Virol; 2019 Aug 01; 93(15):. PubMed ID: 31118257
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever.
    Oestereich L, Rieger T, Lüdtke A, Ruibal P, Wurr S, Pallasch E, Bockholt S, Krasemann S, Muñoz-Fontela C, Günther S.
    J Infect Dis; 2016 Mar 15; 213(6):934-8. PubMed ID: 26531247
    [Abstract] [Full Text] [Related]

  • 15. Severe mammarenaviral disease in guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravir.
    Westover JB, Naik S, Bailey KW, Wandersee L, Gantla VR, Hickerson BT, McCormack K, Henkel G, Gowen BB.
    Antiviral Res; 2022 Dec 15; 208():105444. PubMed ID: 36243175
    [Abstract] [Full Text] [Related]

  • 16. Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (Junin virus) in guinea pigs.
    Kenyon RH, Canonico PG, Green DE, Peters CJ.
    Antimicrob Agents Chemother; 1986 Mar 15; 29(3):521-3. PubMed ID: 3013087
    [Abstract] [Full Text] [Related]

  • 17. Modified ribavirin analogues as antiviral agents against Junín virus.
    Contin M, Sepúlveda C, Fascio M, Stortz CA, Damonte EB, D'Accorso NB.
    Bioorg Med Chem Lett; 2019 Feb 15; 29(4):556-559. PubMed ID: 30612844
    [Abstract] [Full Text] [Related]

  • 18. Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.
    Raabe VN, Kann G, Ribner BS, Morales A, Varkey JB, Mehta AK, Lyon GM, Vanairsdale S, Faber K, Becker S, Eickmann M, Strecker T, Brown S, Patel K, De Leuw P, Schuettfort G, Stephan C, Rabenau H, Klena JD, Rollin PE, McElroy A, Ströher U, Nichol S, Kraft CS, Wolf T, Emory Serious Communicable Diseases Unit.
    Clin Infect Dis; 2017 Sep 01; 65(5):855-859. PubMed ID: 29017278
    [Abstract] [Full Text] [Related]

  • 19. Treatment of Argentine hemorrhagic fever.
    Enria DA, Briggiler AM, Sánchez Z.
    Antiviral Res; 2008 Apr 01; 78(1):132-9. PubMed ID: 18054395
    [Abstract] [Full Text] [Related]

  • 20. A Proteomics Survey of Junín Virus Interactions with Human Proteins Reveals Host Factors Required for Arenavirus Replication.
    Ziegler CM, Eisenhauer P, Kelly JA, Dang LN, Beganovic V, Bruce EA, King BR, Shirley DJ, Weir ME, Ballif BA, Botten J.
    J Virol; 2018 Feb 15; 92(4):. PubMed ID: 29187543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.